Trial Profile
Phase Ib Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Feb 2021
Price :
$35
*
At a glance
- Drugs OPB 111077 (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 10 Feb 2021 Status changed from recruiting to completed.
- 08 Dec 2020 Results (n=12) presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology
- 21 Sep 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.